Commission Implementing Regulation (EU) 2015/1106 of 8 July 2015 amending Implementing Regulations (EU) No 540/2011 and (EU) No 1037/2012 as regards the conditions of approval of the active substance isopyrazam (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2015/1106
• Articles: 3

Article 1 Amendments to Implementing Regulation (EU) No 540/2011

In the column ‘Specific provisions’ of row 27, isopyrazam, of Part B of the Annex to Implementing Regulation (EU) No 540/2011, the last paragraph is replaced by the following:

‘The applicant shall submit to the Commission, the Member States and the Authority this information by 31 July 2017.’

Article 2 Amendments to Implementing Regulation (EU) No 1037/2012

In the column ‘Specific provisions’ of the Annex to Implementing Regulation (EU) No 1037/2012, the last paragraph is replaced by the following:

‘The applicant shall submit to the Commission, the Member States and the Authority this information by 31 July 2017.’

Article 3 Entry into force

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .